Julie Burgess insider trades

Open-market stock purchases and sales by Julie Burgess, Chief Accounting Officer at Design Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2021.

Recent trades

DateStockTradeValue
Jan 2, 2026DSGN Design Therapeutics, IncBought (not open market)—

Companies traded

  • DSGN Design Therapeutics, Inc: other filings, last Jan 2, 2026

Get free alerts when Julie Burgess files a new trade →